A new law gives Medicaid regulators power to threaten drugmakers with cost-effectiveness scrutiny unless they grant additional rebates.
A look at how and why strategic, star-studded advertising brought a drug for a little-known neurological condition into your home.
Even though the GOP health plan is stalled by intraparty negotiations, some big insurance changes are still in the works.
Spending on consumer advertising by drugmakers has increased 62 percent since 2012.
With Republicans in control of Congress and the White House, HSAs — a longtime favorite of conservatives — are likely to get a boost.
“Portability” will likely be a buzz word in the health law repeal-and-replace debate, but the concept raises a number of complicated policy issues.
As Republicans consider how to bring down costs for younger people, lawmakers may relax or eliminate the restrictions on how much more insurers can charge older consumers.
Republicans hope to expand the use of health savings accounts to encourage consumers to be more judicious in using their coverage. Here’s an explainer of how they work.
An analysis of claims data from 60 health insurers found a significant increase in the amount of treatments sought by young people for conditions traditionally associated with older people, such as high blood pressure and sleep apnea.
La Ley de Cuidado de salud Asequible afectó las primas y la cobertura de condiciones preexistentes. Pero el texto de más de 2.000 páginas contiene provisiones que afectan a diario a los estadounidenses.
It’s unclear what will become of some of the rules and regulations advanced by the 2010 health law as Republicans in Congress work to dismantle the sweeping measure.
The Centers for Medicare & Medicaid Innovation was charged by the health law with exploring payment reforms that could cut health care costs and possibly improve quality. But its future is hinged to whether GOP lawmakers see value in its work.
En 2017, muchos más planes de salud en los mercados de seguros requerirán que los consumidores paguen una sustancial parte del costo de los medicamentos más caros, dicen, para disuadir a pacientes muy enfermos de elegir sus planes.
A Kaiser Health News analysis finds that the portion of federal marketplace plans requiring people to pay a third or more of the cost of specialty drugs have jumped from 37 to 63 percent since 2014.
Why an obscure revenue raiser for the Affordable Care Act has found its way into a number of congressional campaign ads.
Some major insurance companies are opting not to pay commissions for plans sold on the Affordable Care Act’s marketplaces. Will this decision make enrollment season more difficult for consumers?
KHN’s Julie Appleby joined forces with USA Today to create this chart, which details the various industry players and how they contribute to a prescription drug’s cost.
High-intensity focused ultrasound, often not covered by insurance, leads to discussions about which patients benefit in the real world.
The number of prescriptions for Medicare beneficiaries is on the rise, too.
The flu vaccine is available for longer windows of time. Experts say to weigh convenience and science in deciding when to roll up your sleeve.